{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-053523","form_type":"8-K","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2025-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.536644+00:00","generated_at":"2026-05-23T15:19:00.380852+00:00","sec_items":["1.01","3.02","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Alaunos raises $500K via Series A-1 Convertible Preferred to Watermill Asset Management","bullets":["500 shares of Series A-1 Convertible Preferred at $1,000/share sold to Watermill Asset Management for $500K total.","Preferred shares carry 10% annual dividend payable in kind; convertible to common at $2.76 per share.","1,601,252 common shares outstanding; preferred votes with common on as-converted basis.","Closing occurred April 11, 2025; proceeds for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-053523","json":"https://secwatch.observer/filing/0000950170-25-053523.json","markdown":"https://secwatch.observer/filing/0000950170-25-053523.md","text":"https://secwatch.observer/filing/0000950170-25-053523.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025053523/0000950170-25-053523-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025053523/tcrt-20250411.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:19:00.380852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}